Gujarat Kidney, a company in the Hospital industry, reported revenue of ₹38 crore and net profit of ₹6.60 crore for the September 2026 quarter.
Gujarat Kidney (NSE: GKSL) closed at ₹149.28 on 20 Nov 2026. Its market capitalisation is ₹1,177 crore and it trades at 62.0 times earnings.
Incorporated in 2019, Gujarat Kidney and Super Speciality Limited specializes in providing multispeciality healthcare services.
Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.